285 related articles for article (PubMed ID: 26462866)
1. Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
Diabetes Obes Metab; 2016 Feb; 18(2):142-51. PubMed ID: 26462866
[TBL] [Abstract][Full Text] [Related]
2. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
[TBL] [Abstract][Full Text] [Related]
3. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
[TBL] [Abstract][Full Text] [Related]
5. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
6. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
7. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
Choi RY; Ham JR; Lee MK
Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
[TBL] [Abstract][Full Text] [Related]
8. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
Tang XH; Melis M; Lu C; Rappa A; Zhang T; Jessurun J; Gross SS; Gudas LJ
J Biol Chem; 2021 Dec; 297(6):101331. PubMed ID: 34688661
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice.
Kondoh M; Shimada T; Fukada K; Morita M; Katada K; Higashimura Y; Mizushima K; Okamori M; Naito Y; Yoshikawa T
Br J Nutr; 2014 Sep; 112(6):868-75. PubMed ID: 25089585
[TBL] [Abstract][Full Text] [Related]
10. Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice.
Tsuneki H; Nagata T; Fujita M; Kon K; Wu N; Takatsuki M; Yamaguchi K; Wada T; Nishijo H; Yanagisawa M; Sakurai T; Sasaoka T
Endocrinology; 2016 Jan; 157(1):195-206. PubMed ID: 26492471
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease.
Abegg K; Bernasconi L; Hutter M; Whiting L; Pietra C; Giuliano C; Lutz TA; Riediger T
Diabetes Obes Metab; 2017 Dec; 19(12):1740-1750. PubMed ID: 28544245
[TBL] [Abstract][Full Text] [Related]
13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
[TBL] [Abstract][Full Text] [Related]
16. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
17. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
[TBL] [Abstract][Full Text] [Related]
18. Effect of Centaurium erythraea Rafn, Artemisia herba-alba Asso and Trigonella foenum-graecum L. on liver fat accumulation in C57BL/6J mice with high-fat diet-induced type 2 diabetes.
Hamza N; Berke B; Cheze C; Marais S; Lorrain S; Abdouelfath A; Lassalle R; Carles D; Gin H; Moore N
J Ethnopharmacol; 2015 Aug; 171():4-11. PubMed ID: 26023031
[TBL] [Abstract][Full Text] [Related]
19. Metformin increases hepatic leptin receptor and decreases steatosis in mice.
Tang X; Li J; Xiang W; Cui Y; Xie B; Wang X; Xu Z; Gan L
J Endocrinol; 2016 Aug; 230(2):227-37. PubMed ID: 27288055
[TBL] [Abstract][Full Text] [Related]
20. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
Melis M; Tang XH; Trasino SE; Patel VM; Stummer DJ; Jessurun J; Gudas LJ
PLoS One; 2019; 14(1):e0211071. PubMed ID: 30677086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]